{
  "docId": "019dd923-622c-750b-8b9a-cb61f3b5c0ba",
  "docSlug": "bb36c74f657a",
  "documentTitle": "Pulse Biosciences (PLSE)",
  "authorId": "61_White_Diamond_Research",
  "authorName": "White Diamond Research",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2025-05-03 00:00:00",
  "orientation": "portrait",
  "aspectRatio": 0.77272725,
  "pageNumber": 7,
  "pageCount": 13,
  "prevPage": 6,
  "nextPage": 8,
  "slideType": "preempt_rebuttal",
  "function": "preempt_rebuttal",
  "density": "dense",
  "nDataPoints": 1,
  "notes": "Includes an AI-generated summary box at the top and specific patent quote excerpts to support the argument.",
  "elementsJson": [
    "paragraph",
    "callout_box"
  ],
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-cb61f3b5c0ba/7",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-cb61f3b5c0ba",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-cb61f3b5c0ba.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-cb61f3b5c0ba#slide-7",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.6,
        "x": 0.24,
        "y": 0.09
      },
      "kind": "callout",
      "text": "While pulsed field ablation (PFA) is primarily known for its use in atrial fibrillation (AFib) treatment, it's also being explored for ventricular arrhythmias.",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4dd2c1d0-1685-4d14-a213-9863ae1d450e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "callout",
      "text": "It's clear that Farapulse had done thorough diligence and experimentation, and decided that micro-second PFA is better than nano-second PFA.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-70fa-7556-8663-912df477254e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.85,
        "x": 0.08,
        "y": 0.65
      },
      "kind": "list",
      "text": "“In some embodiments, the pulse time duration of each biphasic pulse is in the range from about 0.5 nanosecond to about 20 microseconds.”",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fa89869b-2823-4fad-a6d6-b608bd56ba62",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "cash burn: $50M+",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd953-70fa-7556-8663-9b838eca830d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.85,
        "x": 0.08,
        "y": 0.81
      },
      "kind": "paragraph",
      "text": "It’s clear that Farapulse had done thorough diligence and experimentation, and decided that micro-second PFA is better than nano-second PFA. Otherwise, there is nothing stopping them from going the nano-second route.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6aaa70f6-b927-4299-b0d8-cbe286c87a0a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.85,
        "x": 0.08,
        "y": 0.47
      },
      "kind": "paragraph",
      "text": "Farapulse is the market leader in PFA and was acquired by Boston Scientific (BSX) in 2021 for about $500M. It had already been studying nano-second PFA for years before PLSE was ever involved in PFA and before PLSE had any patents for it.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "97e4f755-c5dd-4a6e-b9a9-38a9ad8bc6ed",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.85,
        "x": 0.08,
        "y": 0.27
      },
      "kind": "paragraph",
      "text": "Dr. Reddy claimed “time will tell” if nano-second PFA has any advantages. This presentation was over a year ago. We’ve looked at Dr. Reddy’s public statements since then and we haven’t seen him change his tune on nano-second PFA.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b5dbb9d6-38ab-436c-a96d-5128ff8a1514",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "\"In some embodiments, the pulse time duration of each biphasic pulse is in the range from about 0.5 nanosecond to about 20 microseconds.\" — Farapulse Patent Description",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-70fa-7556-8663-9703810d16aa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.85,
        "x": 0.08,
        "y": 0.41
      },
      "kind": "title",
      "text": "Farapulse Has Already Studied Nano-Pulse Technology for Pulsed Field Ablation Years Before Pulse Biosciences Did",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "20d4c037-2cb8-4e8d-8dcb-3a90c77d3d01",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "preempt_rebuttal",
      "slug": null,
      "matchId": "25f1b4f8-53a0-4b90-8980-58a800bf959c",
      "evidence": "The slide explicitly challenges the bullish thesis on PLSE by citing the actions of a market leader (Farapulse) to invalidate the technology's potential.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 7,
      "from": 7,
      "beatId": "c416d54e-d670-401f-92d4-f4dd508f0a11",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "Preempt Rebuttal",
      "beatSlug": null,
      "evidence": "The document preempts potential rebuttals by discussing Farapulse's prior research and its implications for Pulse Biosciences.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}